Evidence map›Paper›PMID 18180310›Full record

ArticleThe Journal of experimental medicine2008

Mannose-binding lectin enhances Toll-like receptors 2 and 6 signaling from the phagosome.

W K Eddie Ip, Kazue Takahashi, Kathryn J Moore, Lynda M Stuart, R Alan B Ezekowitz

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 75 papers.

0numbers the graph read from it
0cells of the map it votes in
75citing papers in PubMed
6.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

75 citing papers in PubMed, 160 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Collectins: Innate Immune Pattern Recognition Molecules.Advances in experimental medicine and biology · 2020
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Toll-like receptor 2 promiscuity is responsible for the immunostimulatory activity of nucleic acid nanocarriers.Journal of controlled release : official journal of the Controlled Release Society · 2017
    Article
  20. Review

15 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

W K Eddie IpLaboratory of Developmental Immunology, Department of Pediatrics, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA. eddie_ip@hms.harvard.edu
Kazue Takahashi
Kathryn J Moore
Lynda M Stuart
R Alan B Ezekowitz
Massachusetts General Hospital · USUniversity of Edinburgh · GB

Funding

Wellcome TrustWellcome Trust R36731
6 · The paper itself

Abstract

Innate immunity is the first-line defense against pathogens and relies on phagocytes, soluble components, and cell-surface and cytosolic pattern recognition receptors. Despite using hard-wired receptors and signaling pathways, the innate immune response demonstrates surprising specificity to different pathogens. We determined how combinatorial use of innate immune defense mechanisms defines the response. We describe a novel cooperation between a soluble component of the innate immune system, the mannose-binding lectin, and Toll-like receptor 2 that both specifies and amplifies the host response to Staphylococcus aureus. Furthermore, we demonstrate that this cooperation occurs within the phagosome, emphasizing the importance of engulfment in providing the appropriate cellular environment to facilitate the synergy between these defense pathways.

Indexed as

AnimalsCell LineComplement ActivationEvolution, MolecularHumansImmune SystemImmunity, InnateMannose-Binding LectinMiceMice, Inbred C57BLModels, BiologicalPhagosomesProtein Array AnalysisStaphylococcus aureusToll-Like Receptor 2Toll-Like Receptor 6Mannose-Binding LectinTlr2 protein, mouseTlr6 protein, mouseToll-Like Receptor 2Toll-Like Receptor 6

Identifiers

PMID18180310
PMCPMC2234382
OpenAlexW2165292104

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.